NCT00909350

Brief Summary

This is a laboratory-based, exploratory study using tissue obtained from our clinical practice. The purpose of this study is to confirm our ability to characterize miR expression in various tissues (proximal and distal esophagus, stomach and duodenum) obtained from the upper gastrointestinal tract in preparation for the study of MiR in patients with Barrett's esophagus and other inflammatory conditions of the upper gastrointestinal tract.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2008

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 28, 2009

Completed
Last Updated

February 12, 2015

Status Verified

February 1, 2015

Enrollment Period

7 months

First QC Date

May 27, 2009

Last Update Submit

February 11, 2015

Conditions

Keywords

Barrett's esophagusBEesophageal adenocarcinomaMicro-RNAmiR expression

Outcome Measures

Primary Outcomes (1)

  • miR expression between tissue from Barrett's esophagus and that from normal tissues

    time it takes to have standard of care biopsies taken during one routine Upper Endoscopy

Secondary Outcomes (1)

  • expression of miR in Barrett's esophagus patients with cancer in comparison to those who do not progress to cancer

    time it takes to have standard of care biopsies during one routine Upper Endoscopy

Study Arms (1)

No treatment

genetic research project; to meet inclusion criteria, participants must have normal upper GI tract upon upper endoscopy, for study biopsies to be taken

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study subjects identified from individuals referred for upper endoscopy at Mayo Clinic in Jacksonville, Florida

You may qualify if:

  • willingness to give consent
  • normal gross appearance of the esophagus, stomach and duodenum

You may not qualify if:

  • contraindication to mucosal biopsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Jacksonville, Florida, 32224, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

biopsy tissue from proximal and distal esophagus, stomach and duodenum

MeSH Terms

Conditions

Barrett EsophagusAdenocarcinoma Of Esophagus

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Kenneth R. DeVault,, M.D.

    Mayo Clinic, Jacksonville, Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair, Department of Medicine, Mayo Clinic, Jacksonville Florida

Study Record Dates

First Submitted

May 27, 2009

First Posted

May 28, 2009

Study Start

April 1, 2008

Primary Completion

November 1, 2008

Study Completion

November 1, 2008

Last Updated

February 12, 2015

Record last verified: 2015-02

Locations